Virtual Reality-Based Transitional Care for ICU Survivors
VRICU
Impact of a Virtual Reality-Based Transitional Care Program on Heart Rate Variability, Pain, Relocation Stress, and Unplanned ICU Readmission Among Adult ICU Survivors: A Randomized Controlled Trial
1 other identifier
interventional
150
1 country
2
Brief Summary
This study aims to evaluate the effectiveness of a virtual reality (VR)-based transitional care program for adult survivors of intensive care unit (ICU) care. ICU survivors frequently experience relocation stress, anxiety, pain, and physiological instability after transfer from the ICU to general wards, which may increase the risk of unplanned ICU readmission. Participants will be randomly assigned to receive either standard transitional care or additional VR-based intervention sessions during their ICU stay. The VR intervention is designed to provide psychological support, environmental orientation, and stress reduction. Primary outcomes include short-term physiological indicators within 48 hours after ICU transfer. Secondary outcomes include pain, relocation stress, and unplanned ICU readmission within 7 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2026
CompletedStudy Start
First participant enrolled
March 9, 2026
CompletedFirst Posted
Study publicly available on registry
March 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
March 19, 2026
March 1, 2026
11 months
March 3, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Heart Rate Variability - RMSSD
Heart rate variability measured using the Root Mean Square of Successive Differences (RMSSD) derived from electrocardiographic recordings.
Within 48 hours after transfer from the ICU to the general ward
Heart Rate Variability - High Frequency Power
Heart rate variability measured using high-frequency (HF) power derived from electrocardiographic recordings.
Within 48 hours after transfer from the ICU to the general ward
Secondary Outcomes (3)
Pain Intensity
Within 48 hours after ICU transfer
Unplanned ICU Readmission
Within 7 days after ICU transfer
Relocation Stress
Within 48 hours after ICU transfer
Study Arms (2)
VR Intervention Group
EXPERIMENTALParticipants receive standard transitional care plus three VR sessions during ICU stay.
Standard Care Group
NO INTERVENTIONParticipants receive standard ICU transitional care without VR intervention.
Interventions
Participants assigned to this arm will receive three structured virtual reality (VR) sessions during their ICU stay in addition to standard transitional care. Each VR session is designed to provide environmental orientation, psychological support, and stress reduction through immersive audiovisual content. The intervention aims to improve short-term physiological stability and reduce relocation stress following ICU transfer.
Eligibility Criteria
You may qualify if:
- Age 20 years or older
- Adult patients admitted to the intensive care unit (ICU)
- Planned transfer from ICU to the general ward
- Able to communicate and provide informed consent or have a legal representative provide consent
You may not qualify if:
- Severe cognitive impairment or delirium preventing participation
- Severe visual or hearing impairment interfering with VR use
- Hemodynamic instability requiring immediate life-saving intervention
- Isolation precautions prohibiting device use
- Participation in another interventional study that may affect outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
MacKay Memorial Hospital
Taipei, Taipei City, 104, Taiwan
MacKay Memorial Hospital, Tamsui Branch
New Taipei City, 251, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Te-Yu Wu, PhD
MacKay Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, MacKay Medical University
Study Record Dates
First Submitted
March 3, 2026
First Posted
March 19, 2026
Study Start
March 9, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
March 19, 2026
Record last verified: 2026-03